Comparison

Linderane European Partner

Item no. TMO-T6S1894-10mg
Manufacturer TargetMol
CASRN 13476-25-0
Amount 10mg
Category
Type Molecules
Specific against other
Purity 98.25%
Citations Wang H, et al. Mechanism-based inactivation of CYP2C9 by linderane. Xenobiotica. 2015;45(12):1037-46.
Smiles Cc1coc2C\C(C)=C\CC[C@]34O[C@H]3[C@@H](OC4=O)c12
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias 13476-25-0, P450
Available
Short Description
1. Linderane was characterized as a mechanism-based inactivator of CYP2C9.
Shipping
cool pack
Storage
-20°
Molecular Weight
260, 28
Pathway
Metabolism
Target
P450

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10mg
Available: In stock
available

Delivery expected until 8/30/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close